Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer
- 1 March 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (6) , 481-492
- https://doi.org/10.1038/sj.gt.3301123
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 53 references indexed in Scilit:
- MHC Class I–Restricted CTL Responses to Exogenous AntigensImmunity, 1996
- Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cellsImmunology, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genesEuropean Journal of Immunology, 1995
- Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisitedImmunology Today, 1993
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.The Journal of Experimental Medicine, 1992
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus VaccineJNCI Journal of the National Cancer Institute, 1992
- Macrophage activation by interferon‐γ from host‐protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease‐promoting T cells in leishmaniasisEuropean Journal of Immunology, 1989
- B-Cell Stimulatory Factor-1/Interleukin 4Annual Review of Immunology, 1987